1. Home
  2. KEQU vs CDXS Comparison

KEQU vs CDXS Comparison

Compare KEQU & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEQU
  • CDXS
  • Stock Information
  • Founded
  • KEQU 1906
  • CDXS 2002
  • Country
  • KEQU United States
  • CDXS United States
  • Employees
  • KEQU N/A
  • CDXS N/A
  • Industry
  • KEQU Medical Specialities
  • CDXS Major Chemicals
  • Sector
  • KEQU Industrials
  • CDXS Industrials
  • Exchange
  • KEQU Nasdaq
  • CDXS Nasdaq
  • Market Cap
  • KEQU 183.8M
  • CDXS 176.4M
  • IPO Year
  • KEQU N/A
  • CDXS 2010
  • Fundamental
  • Price
  • KEQU $35.16
  • CDXS $2.46
  • Analyst Decision
  • KEQU
  • CDXS Buy
  • Analyst Count
  • KEQU 0
  • CDXS 2
  • Target Price
  • KEQU N/A
  • CDXS $11.00
  • AVG Volume (30 Days)
  • KEQU 17.8K
  • CDXS 508.4K
  • Earning Date
  • KEQU 06-25-2025
  • CDXS 05-14-2025
  • Dividend Yield
  • KEQU N/A
  • CDXS N/A
  • EPS Growth
  • KEQU 102.06
  • CDXS N/A
  • EPS
  • KEQU 5.90
  • CDXS N/A
  • Revenue
  • KEQU $220,026,000.00
  • CDXS $59,345,000.00
  • Revenue This Year
  • KEQU N/A
  • CDXS $12.62
  • Revenue Next Year
  • KEQU N/A
  • CDXS $22.11
  • P/E Ratio
  • KEQU $5.91
  • CDXS N/A
  • Revenue Growth
  • KEQU 9.44
  • CDXS N/A
  • 52 Week Low
  • KEQU $30.33
  • CDXS $1.90
  • 52 Week High
  • KEQU $71.33
  • CDXS $6.08
  • Technical
  • Relative Strength Index (RSI)
  • KEQU 49.72
  • CDXS 51.79
  • Support Level
  • KEQU $30.78
  • CDXS $2.23
  • Resistance Level
  • KEQU $33.32
  • CDXS $2.59
  • Average True Range (ATR)
  • KEQU 1.73
  • CDXS 0.14
  • MACD
  • KEQU 0.80
  • CDXS 0.05
  • Stochastic Oscillator
  • KEQU 96.41
  • CDXS 70.45

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: